Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1673 1693
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18025380 | NOVEL USE OF SACCHARIDE ISOMERATE | Non-Final OA | DSM IP Assets B.V. |
| 17413664 | STABLE AQUEOUS COMPOSITION COMPRISING OLIGOSACCHARIDES | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17759251 | Sugar Chain and Compositions Thereof and Use Thereof in Prevention and/or Treatment of Coronavirus Infection | Final Rejection | Institute of Process Engineering, Chinese Academy of Sciences |
| 18042741 | Hygromycin A Compositions and Methods of Use | Non-Final OA | NORTHEASTERN UNIVERSITY |
| 18597314 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18655876 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | Non-Final OA | Gilead Sciences, Inc. |
| 18555768 | CELLULOSE-BASED FILAMENTS, FILMS AND 3D OBJECTS AND METHODS OF MANUFACTURE THEREOF | Non-Final OA | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY |
| 18261499 | METHOD OF PREPARATION OF CARBOXYMETHYL CELLULOSE HAVING IMPROVED STORAGE STABILITY | Non-Final OA | NUTRITION & BIOSCIENCES USA 1, LLC |
| 18251358 | COMPOSITIONS COMPRISING METHYL CYCLODEXTRINS FOR THE TREATMENT AND/OR PREVENTION OF HEPATIC STEATOSIS | Non-Final OA | ROQUETTE FRERES |
| 18294572 | IRON COMPLEX COMPOUNDS FOR SUBCUTANEOUS USE IN THERAPY OF IRON DEFICIENCY IN COMPANION ANIMALS | Non-Final OA | PHARMACOSMOS HOLDING A/S |
| 17620541 | AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME | Final Rejection | CELGENE CORPORATION |
| 18278728 | HAIR GROWTH AGENT | Non-Final OA | ADJUVANT HOLDINGS CO., LTD. |
| 18287136 | A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF | Non-Final OA | Studiengesellschaft Kohle gGmbH |
| 17907716 | TREATMENT OF CORONAVIRUS INFECTIONS | Non-Final OA | TX MEDIC AB |
| 17785295 | LARGE SCALE PROCESS | Final Rejection | GALECTO BIOTECH AB |
| 18210356 | PROCESS OF FRACTIONATION AND RECOVERY OF FLAVONOIDS, TERPENES AND PREBIOTIC FIBER CONTAINING POLYSACCHARIDES FROM PLANT MATERIAL, USE OF PLANT MATERIAL, AND FLAVONOIDS, TERPENES AND PREBIOTICAL FIBER CONTAINING POLYSACCHARIDES | Non-Final OA | FIBER CITRUS INDÚSTRIA E COMÉRCIO LTDA. |
| 18038351 | HIGH-PURITY ß-NICOTINAMIDE MONONUCLEOTIDE (NMN) AND METHOD FOR PRODUCING SAME | Non-Final OA | MIRAILAB BIOSCIENCE INC. |
| 18196972 | TOPICAL COMPOSITIONS | Non-Final OA | Prime Performance Research LLC |
| 18127421 | USE OF GABAA RECEPTOR AS TARGET IN PREPARATION OR SCREENING OF DRUG FOR LOWERING BLOOD LIPID LEVEL, TREATING OBESITY, AND/OR IMPROVING METABOLISM | Non-Final OA | RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE |
| 18022570 | PROCESS FOR PREPARING SUGAMMADEX | Final Rejection | Werthenstein BioPharma GMBH |
| 18169266 | Uses of a saponin and method for its isolation | Non-Final OA | Freie Universität Berlin |
| 17909318 | ANTIMICROBIAL TARGET | Non-Final OA | UNIVERSITY OF SHEFFIELD |
| 17800271 | METHODS FOR MONITORING THE PROGRESS OF POLYSACCHARIDE SIZE-REDUCTION | Final Rejection | Michelle H. CHEN |
| 17631209 | PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | Final Rejection | Lexicon Pharmaceuticals, Inc. |
| 17596741 | USE OF ALGINATE OLIGOMERS IN THE ANTICOAGULATION THERAPY OF SUBJECTS AT RISK OF BLOOD CLOTS WHICH HAVE AN ABNORMALLY DENSE MICROSTRUCTURE | Final Rejection | AlgiPharma AS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy